Glycyl-L-Leucine in Water-Free Serums: Solvent Compatibility
Glycyl-L-Leucine Solubility Anomalies in Propylene Glycol vs. Butylene Glycol at Elevated Temperatures: Precipitation Risks and Phase Separation Thresholds
In water-free serum formulations, the solubility behavior of Glycyl-L-Leucine (CAS 869-19-2) diverges significantly between propylene glycol (PG) and butylene glycol (BG). While both glycols serve as common anhydrous carriers, their interaction with this dipeptide—also referred to as N-Glycyl-L-leucine or GLY-LEU—is governed by distinct thermodynamic profiles. At ambient temperatures (20–25°C), Glycyl-L-Leucine exhibits moderate solubility in PG (~2–5% w/w), but this drops sharply below 15°C, where we have observed needle-like crystal formation within 48 hours. In contrast, BG maintains a broader solubilization window, with stable solutions up to 8% w/w at 25°C, and no precipitation even after 72 hours at 10°C. However, at elevated temperatures (>60°C), PG becomes the superior solvent, dissolving up to 12% w/w without phase separation, whereas BG solutions above 8% w/w tend to develop a faint haze upon cooling—a sign of micro-crystallization. This hysteresis is critical for R&D managers designing heat-assisted mixing protocols. A non-standard parameter we've encountered in field trials is the viscosity shift in PG-based serums at sub-zero storage (−5°C): the solution thickens considerably, which can impede pump dispensing. This is not a stability issue per se, but a handling consideration for cold-chain logistics. For those exploring synthesis route optimization, our detailed analysis of Glycyl-L-Leucine SPPS aggregation control provides insights into how residual coupling agents can influence solubility. As a drop-in replacement for other Gly-Leu sources, our product matches the purity profiles of leading brands while offering cost efficiencies and reliable supply from our ISO-certified facility.
Compatibility Matrix of Glycyl-L-Leucine with Chelating Agents and pH Adjusters in Anhydrous Serum Formulations
Formulating with Glycyl-L-Leucine (also known as H-Gly-Leu-OH) in anhydrous systems requires careful selection of co-ingredients to avoid destabilization. Chelating agents like EDTA or phytic acid, often added for metal ion sequestration, can interact with the peptide's terminal amine and carboxyl groups. In PG-based serums, disodium EDTA at 0.1% w/w shows no adverse effects on clarity or peptide integrity over 3 months at 40°C. However, in BG systems, the same concentration can induce a slight yellowing after 4 weeks at elevated temperatures, likely due to trace metal-catalyzed Maillard reactions. pH adjusters present a unique challenge in water-free environments. While Glycyl-L-Leucine is typically used in its zwitterionic form, the addition of organic acids (e.g., citric acid) or bases (e.g., triethanolamine) can cause localized protonation shifts, leading to transient precipitation. We recommend pre-dissolving the peptide in the glycol phase before adding any acidic or basic modifiers. For high-concentration monoclonal antibody formulations, our research on Glycyl-L-Leucine for high-concentration mAb lyophilization demonstrates how excipient compatibility is maintained even under extreme pH fluctuations during freeze-drying. As a global manufacturer, we ensure batch-to-batch consistency in these interactions, making our Glycyl-L-Leucine a seamless drop-in replacement for existing formulations.
Visual Clarity Markers and COA Parameters for Glycyl-L-Leucine in Water-Free Delivery Systems
In anhydrous serums, visual clarity is a primary quality indicator. Our Glycyl-L-Leucine (L-Leucine N-glycyl) is manufactured to a purity of ≥99.0% by HPLC, with key COA parameters including specific rotation ([α]D20: −20° to −24°, c=1 in water), loss on drying (<0.5%), and residue on ignition (<0.1%). However, a non-standard but critical field observation is the impact of trace impurities on color. Even at 99.5% purity, residual glycine or leucine from the synthesis route can catalyze browning when exposed to trace aldehydes in certain glycol batches. We therefore recommend requesting a COA that includes a "color of solution" test (APHA ≤20) for water-free applications. The table below compares typical specifications for different grades of Glycyl-L-Leucine available from NINGBO INNO PHARMCHEM.
| Parameter | Standard Grade | High Purity Grade | Custom Grade (for anhydrous) |
|---|---|---|---|
| Assay (HPLC) | ≥98.5% | ≥99.0% | ≥99.5% |
| Specific Rotation | −20° to −24° | −21° to −23° | −21.5° to −22.5° |
| Loss on Drying | ≤0.5% | ≤0.3% | ≤0.2% |
| Residue on Ignition | ≤0.2% | ≤0.1% | ≤0.05% |
| Color of Solution (APHA) | ≤30 | ≤20 | ≤10 |
| Heavy Metals (Pb) | ≤10 ppm | ≤5 ppm | ≤2 ppm |
Please refer to the batch-specific COA for exact values. For R&D managers, the "Custom Grade" is recommended for water-free serums where any haze or color shift is unacceptable. Our industrial purity ensures that even at high loading (10% w/w), the serum remains crystal clear after 6 months at 25°C.
Bulk Packaging and Handling of Glycyl-L-Leucine for Industrial R&D: IBC and Drum Specifications
NINGBO INNO PHARMCHEM supplies Glycyl-L-Leucine in packaging tailored to industrial R&D and pilot-scale production. Standard options include 25 kg fiber drums with double PE liners, and for larger volumes, 500 kg IBC (Intermediate Bulk Container) with moisture-barrier liners. The peptide is hygroscopic; thus, all packaging is purged with nitrogen and sealed under low humidity (<30% RH) conditions. For anhydrous formulation work, we recommend ordering in smaller aliquots (1 kg or 5 kg) to minimize repeated opening of bulk containers. Our logistics focus on physical integrity: drums are palletized and shrink-wrapped, while IBCs are secured with steel strapping. We do not claim any specific environmental certifications, but our packaging complies with international transport regulations for non-hazardous chemicals. As a drop-in replacement for other Gly-Leu suppliers, our bulk price is competitive, and we offer flexible manufacturing process adjustments to meet specific purity or particle size requirements. For global shipment, we coordinate with major freight forwarders to ensure timely delivery from our Ningbo facility.
Frequently Asked Questions
What are the optimal glycol ratios for dissolving Glycyl-L-Leucine in anhydrous serums?
For propylene glycol-based systems, a ratio of 1:4 (peptide:PG) at 50°C with stirring for 30 minutes typically yields a clear solution up to 10% w/w. For butylene glycol, a 1:3 ratio at 40°C is effective, but avoid exceeding 8% w/w to prevent cooling-induced haze. Always cool slowly to room temperature while stirring to avoid thermal shock precipitation.
What are the temperature-dependent solubility limits of Glycyl-L-Leucine in common anhydrous solvents?
In propylene glycol, solubility is ~5% at 25°C, ~2% at 10°C, and up to 12% at 60°C. In butylene glycol, it is ~8% at 25°C, ~6% at 10°C, and ~10% at 60°C. In glycerin, solubility is generally lower (<2%) and not recommended for high-load formulations. These values are based on our internal studies; please refer to the batch-specific COA for precise data.
What visual clarity markers indicate phase separation or precipitation in Glycyl-L-Leucine serums?
Phase separation often manifests as a faint opalescence or "silky" swirls when the serum is gently agitated. Under polarized light, micro-crystals appear as bright specks. A more quantitative marker is an increase in turbidity above 10 NTU (nephelometric turbidity units). If the serum develops a persistent haze after cooling, it likely indicates that the solubility limit has been exceeded.
What amino acid helps crepey skin?
While Glycyl-L-Leucine itself is primarily used as a peptide building block, leucine, as a branched-chain amino acid, is known to support skin protein synthesis. In cosmetic formulations, leucine-containing peptides may help improve skin firmness, but direct effects on crepey skin are formulation-dependent.
What is the solvent for leucine?
Leucine has low water solubility (~24 g/L at 25°C) and is practically insoluble in organic solvents. For anhydrous formulations, leucine is often used as a powder or suspended in oils. Glycyl-L-Leucine, being a dipeptide, has modified solubility and can be dissolved in glycols as described above.
Is it better to take HMB or leucine?
This question relates to dietary supplements, not our industrial product. HMB (beta-hydroxy beta-methylbutyrate) is a metabolite of leucine and is used for muscle preservation. The choice depends on the specific health goal and should be discussed with a healthcare professional.
How to get 2.5 g of leucine for breakfast?
This is a nutrition question unrelated to our chemical product. Leucine is found in high-protein foods like eggs, dairy, and meat. A typical serving of chicken breast or whey protein can provide 2.5 g of leucine.
Sourcing and Technical Support
As a leading global manufacturer of peptide building blocks, NINGBO INNO PHARMCHEM offers Glycyl-L-Leucine with consistent quality and competitive bulk pricing. Our technical team can assist with solvent compatibility studies and provide batch-specific COAs to ensure seamless integration into your anhydrous serum formulations. To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.